ibrutinib Articles
Pharmacyclics and Janssen gain third FDA "Breakthrough" designation for ibrutinib; new Ph II data
9 April 2013
Pharmacyclics gets second $50 million milestone from Janssen
21 August 2012
Showing 1-5 of 5 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
